Precision Medicine Company adyn Raises $ 2.5 Million Seed Funding for Personalized Contraception

SEATTLE – (COMMERCIAL THREAD) –adyn, a precision medicine company, today announced it has closed a $ 2.5 million funding round. The cycle was co-led by Lux Capital and M13 with participation from Civilization Ventures, Concrete Rose Capital, Y Combinator, Madrona…